TY  - JOUR
AU  - Zhao, Ming
AU  - Zhou, Yin
AU  - Zhu, Bochen
AU  - Wan, Mengjie
AU  - Jiang, Tingting
AU  - Tan, Qiqun
AU  - Liu, Yan
AU  - Jiang, Juqing
AU  - Luo, Shuaihantian
AU  - Tan, Yixin
AU  - Wu, Haijing
AU  - Renauer, Paul
AU  - Ayala-Gutierrez, Maria Del Mar 
AU  - Castillo-Palma, Maria Jesus
AU  - Ortega-Castro, Rafaela
AU  - Fernandez-Roldan, Concepcion
AU  - Raya, Enrique
AU  - Faria, Raquel
AU  - Carvalho, Claudia
AU  - Alarcon-Riquelme, Marta E
AU  - Xiang, Zhongyuan
AU  - Chen, Jinwei
AU  - Li, Fen
AU  - Ling, Guanghui
AU  - Zhao, Hongjun
AU  - Liao, Xiangping
AU  - Lin, Youkun
AU  - Sawalha, Amr H
AU  - Lu, Qianjin
PY  - 2016
DO  - 10.1136/annrheumdis-2015-208410
UR  - http://hdl.handle.net/10668/9749
T2  - Annals of the rheumatic diseases
AB  - Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease with limited reliable diagnostic biomarkers. We investigated whether gene methylation could meet sensitivity and specificity criteria for a robust biomarker. IFI44L promoter...
LA  - en
PB  - Elsevier
KW  - Autoimmune Diseases
KW  - Gene Polymorphism
KW  - Systemic Lupus Erythematosus
KW  - Adult
KW  - Antigens
KW  - Arthritis, Rheumatoid
KW  - Biomarkers
KW  - Case-Control Studies
KW  - Cytoskeletal Proteins
KW  - DNA Methylation
KW  - Female
KW  - Genetic Markers
KW  - Humans
KW  - Lupus Erythematosus, Systemic
KW  - Male
KW  - Middle Aged
KW  - Promoter Regions, Genetic
KW  - Sensitivity and Specificity
KW  - Sjogren's Syndrome
TI  - IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
TY  - research article
VL  - 75
ER  -